Lamivudine treatment of chronic hepatitis B

Reviews in Medical Virology

Volumn 8, Issue 3, 1998, Pages 153-159

  Dusheiko, Geoffrey ^a  

^a Department of Medicine ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE ANALOG; PLACEBO; VIRUS DNA;

CHRONIC HEPATITIS; DRUG EFFICACY; DRUG RESISTANCE; HEPATITIS B; HISTOLOGY; HUMAN; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVIEW; SEROCONVERSION; VIRUS MUTATION;

EID: 0031822390     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y     Document Type: Review

References (5)

1. Terrault, N. A. (1996). Treatment of chronic hepatitis B and chronic hepatitis C. Rev. Med. Virol. 6, 215-228.
2. Yuen, G. J., Morris, D. M., Mydlow, P. K., Haidar, S., Hall, S. T. and Hussey, E. K. (1995). Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. J. Clin. Pharmacol. 35, 1174-1180.
3. Heald, A. E., Hsyu, P. H., Yuen, G. J., Robinson, P., Mydlow, P. and Bartlett, J. A. (1996). Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. Antimicrob. Agents Chemother. 40, 1514-1519.
4. Rajagopalan, P., Boudinot, F. D., Chu, C. K., Tennant, B. C., Baldwin, B. H., and Schinazi, R. F. (1996). Pharmacokinetics of (-)-2′-3′-dideoxy-3′-thiacytidine in woodchuncks. Antimicrob. Agents Chemother. 40, 642-645.
5. Lai, C. L., Ching, C. K., Tung, A. K. M. et al. (1997). Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial. Hepatology 25, 241-244.